The Partners HealthCare Biobank aims to foster collaborations among investigators, physicians and patients seen at Partners HealthCare hospitals. This enterprise-wide project is at the forefront of developing the tools needed to expedite research and the translation of discoveries into clinical care.

Samples are maintained in an institution-wide repository which is a growing resource available to Partners investigators and research groups. These samples are available for distribution to Partners investigators with required approval from the Partners Institutional Review board (IRB). They are linked to clinical data stored, some additional health information and survey data, and genomic data. The Partners Biobank is also driving a program to genotype 40,000 of the Biobank's participants.

To date, more than 100,000 patients have consented to participate in the Partners Biobank at Brigham and Women’s Hospital, Massachusetts General Hospital, Faulkner Hospital, Newton-Wellesely Hospital, McLean Hospital, North Shore Medical Center, and Spaulding Rehabilitation Network.

Please visit Partners HealthCare Personalized Medicine to learn more about how the Partners Biobank can help you with your research.